1Katoh A, Watzlaf VJ,D'Amico F. An examination of obesity and breast cancer survival in post - menopausal women. Br J Cancer , 1994,70:928 - 933. 被引量：1
2Marret H,Perrotin F,Boagnoux P, et al. Low body mass indez is an independent predictive factor of local recurrence after conservative treatment for breast cancer. Breast Cancer Res Treat, 2001,66:17 -23. 被引量：1
3Daling JR, Malone KE, Doody DR, et al. Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma. Cancer, 2001,92:720 -729. 被引量：1
4Holmberg L, Lund E, Bergstrom R, et al. Oral contraceptives and prognosis in breast cancer: effects of duration, latency, recency, age at first use and relation to parity and body mass index in young women with breast cancer. Ear J Cancer, 1994,30A :351 - 354. 被引量：1
5Flaws JA ,Sheth H ,Tkaczuk K et all. Age and body mass index are associated with the levels of tamoxifen metabolites. Abstract in Era of Hope Breast Cancer Research Program Meeting. US Department of Defense 2002. 被引量：1
6Chlebowski RT, Aiello E, McTieman A: Weighy loss in breast cancer patient management. J Clin Oncol 2002,20 : 1128 - 1143. 被引量：1
7Rowan T. Chlebowski obesity and early - stage breast cancer. Journal of Clinical Oneology, 2005,23 ( 7 ) : 1345 - 1347. 被引量：1
8Daniell HW. Increased lymph node metastases at mastectomy for breast cancer associated with host obesity, cigarette smoking age and large tumor size. Cancer, 1988,62:429 -435. 被引量：1
3MARRET H,PERROTIN F,BOUGNOUX P,et al.Low bodymass index is an independent predictive factor of local recurrenceafter conservative treatment for breast cancer[J].Breast CancerRes Treat,2001,66(1):17-23. 被引量：1
4BERCLAZ G,LI S,PRICE K N,et al.International BreastCancer Study Group.Body mass index as a prognostic feature inoperable breast cancer:the International Breast Cancer StudyGroup experience[J].Ann Oncol,2004,15(6):875-884. 被引量：1
5HEYS S D,OGSTON K,MILLER I,et al.Potentiation of the re-sponse to chemotherapy in patients with breast cancer by dietarysupplementation with L-arginine:results of a randomised con-trolled trial[J].Int J Oncol,1998,12(1):221-225. 被引量：1
6FISHER E R,WANG J,BRYANT J,et al.Pathobiology of pre-operative chemotherapy:findings from the National Surgical Adju-vant Breast and Bowel(NSABP)protocol B-18[J].Cancer,2002,95(4):681-695. 被引量：1
7MAHMOUDI K,MSOLLY A,LANDOLSI A,et al.Retraction:effect of obesity at the pathologic response to neoadjuvant chemo-therapy among premenopausal Tunisian women with breast cancer[J].Obesity(Silver Spring),2011,19(5):1106. 被引量：1
8LITTON J K,GONZALEZ ANGULO A M,WARNEKE C L,et al.Relationship between obesity and pathologic response to neo-adjuvant chemotherapy among women with operable breast cancer[J].J Clin Oncol,2008,26(25):4072-4077. 被引量：1
9BAFALOUKOS D.Neo-adjuvant therapy in breast cancer[J].Ann Oncol,2005,16 Suppl 2:ii174-ii181. 被引量：1
10RENEHAN A G,TYSON M,EGGER M,et al.Body-mass in-dex and incidence of cancer:a systematic review and meta-analy-sis of prospective observational studies[J].Lancet,2008,371(9612):569-578. 被引量：1
